Vered Bisker-Leib
2023
In 2023, Vered Bisker-Leib earned a total compensation of $4.1M as Chief Executive Officer formerly President and COO at Compass Therapeutics, a 136% increase compared to previous year.
Compensation breakdown
| Bonus | $202,500 |
|---|---|
| Option Awards | $1,776,284 |
| Salary | $500,000 |
| Stock Awards | $1,572,000 |
| Other | $16,500 |
| Total | $4,067,284 |
Bisker-Leib received $1.8M in option awards, accounting for 44% of the total pay in 2023.
Bisker-Leib also received $202.5K in bonus, $500K in salary, $1.6M in stock awards and $16.5K in other compensation.
Rankings
In 2023, Vered Bisker-Leib's compensation ranked 176th out of 2,773 executives tracked by ExecPay. In other words, Bisker-Leib earned more than 93.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 176 out of 2,773 | 94th |
Division Manufacturing | 92 out of 1,516 | 94th |
Major group Chemicals And Allied Products | 58 out of 855 | 93rd |
Industry group Drugs | 57 out of 821 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 19 out of 204 | 91st |
Source: SEC filing on April 29, 2024.
Bisker-Leib's colleagues
We found one more compensation record of an executive who worked with Vered Bisker-Leib at Compass Therapeutics in 2023.
2023
Thomas Schuetz
Compass Therapeutics